STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating STAAR Surgical Company for potential violations of securities laws following disappointing Q4 2024 earnings, which led to a significant drop in share price [1][2]. Group 1: Investigation Details - The investigation centers on whether STAAR Surgical made false or misleading statements and failed to disclose important information to investors [2]. - The company's Q4 2024 earnings report indicated weak demand in China and a decline in refractive procedures, contributing to the disappointing results [2]. Group 2: Market Reaction - Following the earnings report, STAAR Surgical's shares experienced a decline of 24.68% on February 12, 2025 [2].